NCT02739347

Brief Summary

This study proposes to assess the effect of trans-cranial direct current stimulation (tDCS) on cognitive control, working memory, functional, clinical, and cognitive outcomes in schizophrenia patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable schizophrenia

Timeline
Completed

Started May 2016

Typical duration for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 15, 2016

Completed
16 days until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

July 7, 2022

Completed
Last Updated

July 7, 2022

Status Verified

June 1, 2022

Enrollment Period

3.1 years

First QC Date

April 5, 2016

Results QC Date

June 29, 2020

Last Update Submit

June 13, 2022

Conditions

Keywords

tDCScognitive controlworking memoryEEGgamma oscillations

Outcome Measures

Primary Outcomes (2)

  • Cognitive Control

    The investigators will assess cognitive control using the Preparing to Overcome Prepotency (POP) task. The accuracy mean differences between the high and low control conditions will be used as dependent measures. The study is powered at 0.8 to observe a post-pre treatment improvement in cognitive control with a substantial effect size (d=0.56) compared to sham stimulation with effects relatively stable measured 2 months after baseline. The hypothesized effect size will be d=0.60.

    Week 1

  • Working Memory

    The investigators will assess working memory using a working memory task. The accuracy mean differences between the high and low control conditions will be used as dependent measures. The study is powered at 0.8 to observe a post-pre treatment improvement in cognitive control with a substantial effect size (d=0.56) compared to sham stimulation with effects relatively stable measured 2 months after baseline. The hypothesized effect size will be d=0.60.

    Week 1

Secondary Outcomes (2)

  • Negative Symptoms

    Week 1

  • Auditory Hallucinations

    Week 1

Study Arms (2)

Active Stimulation

EXPERIMENTAL

Active stimulation group will receive 20 min of 2 mA direct current stimulation.

Device: Active Trans-cranial direct-current stimulation

Sham Stimulation

SHAM COMPARATOR

This will be an active sham involving brief (15 msec) low current (0.11 mA) pulses every 550 ms.

Device: Sham Trans-cranial direct current stimulation

Interventions

Active stimulation group will receive 20 min of 2 mA direct current stimulation.

Also known as: tDCS
Active Stimulation

This will be an active sham involving brief (15 msec) low current (0.11 mA) pulses every 550 ms.

Also known as: tDCS
Sham Stimulation

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Early course psychosis:
  • DSM-V diagnosis of Schizophrenia, Schizoaffective disorder, or schizophreniform disorder.
  • ages 18-50 years
  • on stable doses of medication for at least one month
  • not taking benzodiazepines or mood stabilizers.
  • Mild to severe cognitive impairment in MATRICS Consensus Cognitive Battery (composite scores \< 40)
  • Chronic psychosis:
  • Same as early course psychosis but \>5 years of antipsychotic treatment

You may not qualify if:

  • Diagnostic and Statistical Manual-Version V (DSM-V) diagnosis of mental retardation
  • significant head injury
  • medical illness affecting brain function or structure
  • pregnancy or postpartum (\<6 weeks after delivery or miscarriage)
  • significant neurologic disorder (e.g seizure disorder)
  • inability to provide informed consent
  • significant color blindness that affects task performance
  • Comorbidity for DSM-V substance abuse disorder within the past one month
  • Temporal relation between illness onset and head injury
  • Taking benzodiazepines or mood stabilizers (lithium allowed)
  • Positive drug screen (excluding THC at baseline)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

Related Publications (10)

  • Brunelin J, Mondino M, Gassab L, Haesebaert F, Gaha L, Suaud-Chagny MF, Saoud M, Mechri A, Poulet E. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry. 2012 Jul;169(7):719-24. doi: 10.1176/appi.ajp.2012.11071091.

    PMID: 22581236BACKGROUND
  • Brunoni AR, Nitsche MA, Bolognini N, Bikson M, Wagner T, Merabet L, Edwards DJ, Valero-Cabre A, Rotenberg A, Pascual-Leone A, Ferrucci R, Priori A, Boggio PS, Fregni F. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul. 2012 Jul;5(3):175-195. doi: 10.1016/j.brs.2011.03.002. Epub 2011 Apr 1.

    PMID: 22037126BACKGROUND
  • Cho RY, Konecky RO, Carter CS. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19878-83. doi: 10.1073/pnas.0609440103. Epub 2006 Dec 14.

    PMID: 17170134BACKGROUND
  • Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996 Mar;153(3):321-30. doi: 10.1176/ajp.153.3.321.

    PMID: 8610818BACKGROUND
  • Lisman J, Buzsaki G. A neural coding scheme formed by the combined function of gamma and theta oscillations. Schizophr Bull. 2008 Sep;34(5):974-80. doi: 10.1093/schbul/sbn060. Epub 2008 Jun 16.

    PMID: 18559405BACKGROUND
  • Mondino M, Brunelin J, Palm U, Brunoni AR, Poulet E, Fecteau S. Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions. Curr Pharm Des. 2015;21(23):3373-83. doi: 10.2174/1381612821666150619093648.

    PMID: 26088110BACKGROUND
  • Stagg CJ, Best JG, Stephenson MC, O'Shea J, Wylezinska M, Kincses ZT, Morris PG, Matthews PM, Johansen-Berg H. Polarity-sensitive modulation of cortical neurotransmitters by transcranial stimulation. J Neurosci. 2009 Apr 22;29(16):5202-6. doi: 10.1523/JNEUROSCI.4432-08.2009.

    PMID: 19386916BACKGROUND
  • Stagg CJ, Nitsche MA. Physiological basis of transcranial direct current stimulation. Neuroscientist. 2011 Feb;17(1):37-53. doi: 10.1177/1073858410386614.

    PMID: 21343407BACKGROUND
  • Uhlhaas PJ, Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010 Feb;11(2):100-13. doi: 10.1038/nrn2774.

    PMID: 20087360BACKGROUND
  • Volk DW, Lewis DA. Prefrontal cortical circuits in schizophrenia. Curr Top Behav Neurosci. 2010;4:485-508. doi: 10.1007/7854_2010_44.

    PMID: 21312410BACKGROUND

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Limitations and Caveats

Despite concerted and exhaustive subject recruitment efforts, the total number of patients completing the protocol was minimal. As such the sample size was inadequate for deriving any meaningful descriptive statistics or statistical comparisons.

Results Point of Contact

Title
Raymond Cho
Organization
Baylor College of Medicine

Study Officials

  • Raymond Cho, MD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 5, 2016

First Posted

April 15, 2016

Study Start

May 1, 2016

Primary Completion

June 1, 2019

Study Completion

June 1, 2019

Last Updated

July 7, 2022

Results First Posted

July 7, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will share

Data will be open to sharing after primary findings of study have been published.

Locations